RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
This Quarter Return
+15.44%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$855M
AUM Growth
+$855M
Cap. Flow
-$110M
Cap. Flow %
-12.86%
Top 10 Hldgs %
29.46%
Holding
101
New
12
Increased
18
Reduced
37
Closed
8

Top Buys

1
LIVN icon
LivaNova
LIVN
$11.7M
2
EXAS icon
Exact Sciences
EXAS
$8.66M
3
ABMD
Abiomed Inc
ABMD
$7.76M
4
MGNX icon
MacroGenics
MGNX
$7.64M
5
NKTR icon
Nektar Therapeutics
NKTR
$7.37M

Top Sells

1
BIIB icon
Biogen
BIIB
$18.1M
2
INCY icon
Incyte
INCY
$14.3M
3
CELG
Celgene Corp
CELG
$14.2M
4
SAGE
Sage Therapeutics
SAGE
$13.6M
5
ALXN
Alexion Pharmaceuticals Inc
ALXN
$12.7M

Sector Composition

1 Healthcare 93.64%
2 Technology 0.15%
3 Energy 0.14%
4 Financials 0.1%
5 Communication Services 0.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DPLO
51
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$6.99M 0.82%
1,203,405
– –
DERM
52
DELISTED
Dermira, Inc.
DERM
$6.78M 0.79%
+500,329
New +$6.78M
REGN icon
53
Regeneron Pharmaceuticals
REGN
$59.8B
$6.57M 0.77%
16,000
-1,000
-6% -$411K
CELG
54
DELISTED
Celgene Corp
CELG
$6.2M 0.73%
65,698
-150,000
-70% -$14.2M
CHRS icon
55
Coherus Oncology, Inc. Common Stock
CHRS
$146M
$6.15M 0.72%
451,131
+130,000
+40% +$1.77M
RIGL icon
56
Rigel Pharmaceuticals
RIGL
$710M
$5.82M 0.68%
2,264,942
– –
EW icon
57
Edwards Lifesciences
EW
$47.7B
$5.09M 0.6%
26,585
-40,000
-60% -$7.65M
VRAY
58
DELISTED
ViewRay, Inc.
VRAY
$4.91M 0.57%
664,023
– –
ABBV icon
59
AbbVie
ABBV
$374B
$4.84M 0.57%
60,000
-102,415
-63% -$8.25M
ABEO icon
60
Abeona Therapeutics
ABEO
$356M
$4.78M 0.56%
649,123
– –
ALKS icon
61
Alkermes
ALKS
$4.95B
$4.39M 0.51%
120,399
-54,000
-31% -$1.97M
MDCO
62
DELISTED
Medicines Co
MDCO
$3.63M 0.43%
130,000
-5,000
-4% -$140K
GTHX
63
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$3.52M 0.41%
212,169
+39,349
+23% +$653K
MDGL icon
64
Madrigal Pharmaceuticals
MDGL
$9.7B
$3.41M 0.4%
+27,225
New +$3.41M
RARX
65
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$3.36M 0.39%
+150,000
New +$3.36M
AIMT
66
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$3.34M 0.39%
+149,201
New +$3.34M
XLRN
67
DELISTED
Acceleron Pharma Inc.
XLRN
$3.26M 0.38%
+70,000
New +$3.26M
RVNC
68
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.05M 0.36%
193,181
– –
NSTG
69
DELISTED
NanoString Technologies, Inc.
NSTG
$2.87M 0.34%
+120,000
New +$2.87M
QGEN icon
70
Qiagen
QGEN
$10.1B
$2.44M 0.28%
+60,000
New +$2.44M
DVAX icon
71
Dynavax Technologies
DVAX
$1.19B
$2.08M 0.24%
+285,000
New +$2.08M
FLXN
72
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.46M 0.17%
117,265
-389,700
-77% -$4.86M
PVLA
73
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$1.01M 0.12%
300,000
– –
ACHN
74
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$822K 0.1%
277,800
-125,000
-31% -$370K
EPZM
75
DELISTED
Epizyme, Inc
EPZM
$734K 0.09%
+59,205
New +$734K
1 2
3
4 5